Glukosalina I (Sodium Chloride, Glucose)

Glukosalina I is employed in various clinical situations where fluid, electrolyte, and energy supplementation are required. It may be used for:

• Intravenous rehydration in patients with fluid loss.
• Maintenance of electrolyte balance during surgery.
• Providing a source of glucose for patients unable to eat.
• Dilution and administration of other intravenous medications.
• Support during perioperative fasting periods.
• Treatment of mild hypoglycemia under medical supervision.

Side effects of Glukosalina I are generally related to its components and route of administration.

Common

• Mild local irritation at the infusion site.
• Transient increase in blood glucose levels.
• Slight electrolyte shifts, such as mild hypernatremia.
• Headache or dizziness during rapid infusion.
• Nausea or mild gastrointestinal discomfort.

Serious

• Severe hyperglycemia in susceptible individuals.
• Significant electrolyte imbalance (e.g., hypernatremia, hyperchloremia).
• Allergic reaction presenting as rash, itching, or anaphylaxis.
• Fluid overload leading to pulmonary edema.
• Venous thrombosis at the catheter site.

When using Glukosalina I, healthcare professionals should consider several safety measures. Important precautions include:

• Assessing the patient’s baseline electrolyte and glucose status before infusion.
• Adjusting infusion rate in patients with cardiac or renal impairment to avoid fluid overload.
• Monitoring blood glucose levels in diabetic patients.
• Using aseptic technique to prevent infection at the injection site.
• Avoiding rapid bolus administration unless clinically indicated.
• Observing for signs of allergic reaction during and after infusion.
• Documenting the total volume administered to prevent overhydration.

Glukosalina I may interact with other medications or clinical conditions. Interactions to consider are:

Avoid

• Co-administration with hypertonic glucose solutions that could exacerbate hyperglycemia.
• Simultaneous use of high-dose sodium-containing drugs that may cause severe hypernatremia.
• Intravenous potassium supplements without electrolyte monitoring.

Use with caution

• Concurrent diuretics, which may alter fluid and electrolyte balance.
• Insulin therapy, requiring close glucose monitoring.
• Medications that affect renal function, such as ACE inhibitors.
• Blood thinners, due to potential dilutional effects on coagulation parameters.